dw a 2114r has been researched along with carboplatin in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (23.40) | 18.7374 |
1990's | 36 (76.60) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakai, Y | 1 |
Arai, Y; Hashimura, T; Kamoto, T; Matsuda, T; Oishi, K; Takeuchi, H; Yoshida, O | 1 |
Akamatsu, K; Endo, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Morikawa, K | 1 |
Christian, MC | 1 |
Inoue, S; Ito, M; Mizuno, S; Ohnuma, T | 1 |
Furuhashi, Y; Iwata, M; Kano, T; Kawai, M; Kikkawa, F; Maeda, O; Misawa, T; Morikawa, Y; Oguchi, H; Tomada, Y | 1 |
Fujimoto, S; Hashimoto, M; Kato, T; Nishimura, H; Nishiya, I; Sasaki, H; Terashima, Y; Yajima, A; Yakushiji, M; Yamabe, T | 1 |
Souma, R; Takamoto, S | 1 |
Koizumi, K; Matsumoto, T; Matsuoka, Y; Morikawa, K | 1 |
Ariyoshi, Y; Furue, H; Hasegawa, K; Majima, H; Miyake, H; Niitani, H; Ogawa, M; Sakai, Y; Taguchi, T; Wakui, A | 1 |
Akamatsu, K; Kamisango, K; Koizumi, K; Matsumoto, T; Morikawa, K; Tashiro, T | 1 |
Ariyoshi, Y; Fukuoka, M; Furusawa, M; Hasegawa, K; Kimura, I; Kumoi, T; Kurita, Y; Matsunaga, T; Niitani, H; Tamura, M | 1 |
Aoyama, H; Asaishi, K; Hayasaka, H; Izuo, M; Kubo, K; Majima, H; Ogawa, M; Uchino, J; Wada, T; Yasutomi, M | 1 |
Akamatsu, K; Endo, K; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K | 2 |
Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
Akamatsu, K; Koizumi, K; Matsumoto, T; Mitsui, H | 1 |
Akamatsu, K; Endoh, K; Honda, M; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K | 1 |
Kobayashi, H; Miyachi, H; Ogawa, T; Takemura, Y | 1 |
Akamatsu, K; Endoh, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Matsuno, T; Mitsui, H; Morikawa, K | 1 |
Furuhashi, Y; Iwata, M; Izuta, S; Kojima, K; Suzuki, M; Tomoda, Y; Yoshida, S | 1 |
Abe, O; Furukawa, T; Ishibiki, K; Josui, K; Kase, S; Kodaira, S; Kubota, T; Takahara, T; Takeuchi, T; Yamaguchi, H | 1 |
Araki, Y; Makino, S; Tamura, K | 1 |
Akamatsu, K; Endo, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Matsuno, T; Mitsui, H; Morikawa, K | 2 |
Hiraki, S; Kiura, K; Kozuka, A; Mima, Y; Moritaka, T; Ohnoshi, T; Ueoka, H; Uji, H; Yamashita, H; Yonei, T | 1 |
Honda, M; Itoh, M; Murata, H; Ochi, K; Watanabe, Y | 1 |
Suzumori, K; Yagami, Y; Yasui, Y | 1 |
Furukawa, S; Kubota, A; Miyata, K; Mochimatsu, I; Ryo, I; Sawaki, S; Tukuda, M; Yanoma, S; Yoshida, T | 1 |
Fujita, H; Okamoto, M; Takao, A | 1 |
Majima, H | 1 |
Ariyoshi, Y; Ota, K | 1 |
Akasaka, Y; Machida, T | 1 |
Nishimura, H; Yakushiji, M | 1 |
Hamaguchi, K; Kato, T; Kishi, N; Matsumura, T; Miyahara, K; Nishimura, H; Tashiro, M; Yakushiji, M | 1 |
Akaboshi, M; Kawai, K; Miyahara, T; Takada, S; Ujeno, Y | 1 |
Kudo, C; Saito, M; Yoshida, T | 1 |
Imamiya, S; Maezawa, H; Mori, T; Ohizumi, Y | 1 |
Higashide, K; Kikkawa, F; Maeda, O; Misawa, T; Obata, NH; Suganuma, N; Tomoda, Y | 1 |
Ariyoshi, Y; Ogawa, M | 1 |
Chung, YS; Kato, Y; Kubo, T; Maeda, K; Nakata, B; Nitta, A; Okuno, M; Sowa, M; Yashiro, M | 1 |
Adachi, J; Matsuoka, A; Sugiyama, O; Suzuki, H; Ueda, O | 1 |
Ota, K | 1 |
Inada, T; Kakehi, M; Kubota, N | 1 |
Fujiwara, Y; Nakamura, M; Yokoo, S | 1 |
Kojima, Y; Kotake, T; Maeda, O; Miki, T; Nonomura, N; Okuyama, A; Saiki, S; Sawada, M | 1 |
Bloemink, MJ; Heetebrij, RJ; PĂ©rez, JM; Reedijk, J | 1 |
4 review(s) available for dw a 2114r and carboplatin
Article | Year |
---|---|
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
The current status of new platinum analogs.
Topics: Animals; Antineoplastic Agents; Carboplatin; Chemistry, Pharmaceutical; Cyclobutanes; Drugs, Investigational; Forecasting; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 1992 |
New anticancer drugs under clinical trials in Japan.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Japan; Organoplatinum Compounds | 1994 |
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
6 trial(s) available for dw a 2114r and carboplatin
Article | Year |
---|---|
[Development of platinum analogues for the treatment of lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds | 1992 |
[Phase III study of DWA2114R for ovarian cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms | 1992 |
[A phase II study of DWA2114R, a new platinum complex for breast cancer].
Topics: Anorexia; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Vomiting | 1992 |
A phase I study of a new cisplatin derivative for hematologic malignancies.
Topics: Adult; Antineoplastic Agents; Carboplatin; Drug Administration Schedule; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes | 1990 |
[Current status of CDDP analogs in gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Multicenter Studies as Topic; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Uterine Cervical Neoplasms | 1989 |
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
39 other study(ies) available for dw a 2114r and carboplatin
Article | Year |
---|---|
[Treatment of endocrine-resistant stage D carcinoma of the prostate with a cisplatin derivative (DWA2114R): a pilot study].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Pilot Projects; Prostatic Neoplasms; Remission Induction; Treatment Failure | 1992 |
Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Immunity, Cellular; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; T-Lymphocytes; Time Factors | 1992 |
Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carboplatin; Cell Cycle; Cell Division; Cisplatin; DNA, Neoplasm; Drug Interactions; Flow Cytometry; Humans; Ki-67 Antigen; Kinetics; Lung Neoplasms; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Rhodamine 123; Rhodamines; Subcellular Fractions; Time Factors; Tumor Cells, Cultured | 1992 |
Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cystadenocarcinoma; Female; Humans; Ovarian Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 1992 |
[Flow cytometric analysis of the effect of DWA2114R on the cell cycle traverse of RPMI 8402 cells--comparison with CDDP].
Topics: Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Cisplatin; Flow Cytometry; Humans; Leukemia, T-Cell; Tumor Cells, Cultured | 1992 |
The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cattle; DNA | 1992 |
[A phase I study of DWA2114R].
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carboplatin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Vomiting | 1992 |
Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia P388; Structure-Activity Relationship | 1992 |
[A phase I study on a weekly schedule of DWA2114R].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia | 1992 |
[Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
Topics: Animals; Antineoplastic Agents; Carboplatin; Colonic Neoplasms; Drug Administration Schedule; Injections; Lung Neoplasms; Male; Mice; Tumor Cells, Cultured | 1992 |
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
[Interaction of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato) platinum (II) monohydrate with DNA as determined by a nitrocellulose filter binding assay].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Collodion; DNA; Drug Interactions; Filtration | 1992 |
Synthesis, antitumor activity, and nephrotoxicity of the optical isomers of 2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)platinum(II).
Topics: Animals; Antineoplastic Agents; Carboplatin; Colonic Neoplasms; Kidney; Male; Mice; Neoplasm Transplantation; Stereoisomerism | 1991 |
Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
Topics: Antineoplastic Agents; Carboplatin; Cell Count; Cell Division; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Drugs, Investigational; Humans; Leukemia; Molecular Structure; Organoplatinum Compounds; Tumor Cells, Cultured | 1991 |
Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carboplatin; Isomerism; Kidney; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Tissue Distribution | 1991 |
Sequence-dependent termination of mammalian DNA polymerase reaction by a new platinum compound, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-plati num(II) monohydrate).
Topics: Animals; Antineoplastic Agents; Base Sequence; Carboplatin; Cattle; DNA Polymerase I; DNA Polymerase II; DNA Replication; Molecular Sequence Data; Organoplatinum Compounds; Peptide Chain Elongation, Translational | 1991 |
Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma 256, Walker; Cisplatin; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1991 |
[Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Screening Assays, Antitumor; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Optical Rotation; Organoplatinum Compounds; Rats; Rats, Inbred F344 | 1991 |
[Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Drug Evaluation, Preclinical; Drug Resistance; In Vitro Techniques; Leukemia L1210; Mice; Neoplasm Transplantation; Organoplatinum Compounds | 1990 |
[Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Humans; In Vitro Techniques; Lung Neoplasms; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine.
Topics: Carboplatin; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Guanosine; Magnetic Resonance Spectroscopy; Organoplatinum Compounds | 1989 |
[Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Prognosis; Transplantation, Heterologous; Uterine Neoplasms | 1989 |
[Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Fluorouracil; Humans; In Vitro Techniques; Organoplatinum Compounds; Pharyngeal Neoplasms; Tumor Cells, Cultured | 1989 |
[Pharmacokinetics of new cisplatin analogues in experimental animals].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Mice; Organoplatinum Compounds; Platinum; Protein Binding; Rabbits; Sarcoma 180; Tissue Distribution | 1989 |
[Present status of cisplatin (CDDP) analogues in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemical Phenomena; Chemistry; Cisplatin; Female; Humans; Kidney; Leukopenia; Nervous System; Organoplatinum Compounds; Platinum; Protein Binding; Thrombocytopenia | 1989 |
[Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Cisplatin; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Kidney; Leukopenia; Mice; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Thrombocytopenia | 1989 |
[Experimental evaluation of cisplatin analogous in urogenital cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Evaluation; Humans; Kidney; Leukopenia; Male; Mice; Mice, Inbred Strains; Middle Aged; Organoplatinum Compounds; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testicular Neoplasms; Testis; Thrombocytopenia; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1989 |
[Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
Topics: Animals; Antineoplastic Agents; Carboplatin; Drug Screening Assays, Antitumor; Drug Tolerance; Fibrosarcoma; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organoplatinum Compounds; Weight Loss | 1989 |
Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Cystadenocarcinoma; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms | 1988 |
Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).
Topics: Carboplatin; Cell Division; Cell Survival; Cisplatin; DNA; HeLa Cells; Humans; Platinum; Proteins; RNA | 1994 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
Synergistic effects of hyperthermia and intratumorous injection of anti-cancer drugs.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Lewis Lung; Combined Modality Therapy; Disease Models, Animal; Female; Hyperthermia, Induced; Injections, Intralesional; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Peplomycin | 1993 |
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
Topics: Camptothecin; Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Humans; Organoplatinum Compounds; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |
[An application of in vitro fertilization--embryo culture--embryo transfer system on the drug safety evaluation: fertility test of male mice administered with the anticancer drug].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cells, Cultured; DNA; Drug Evaluation, Preclinical; Embryo Transfer; Female; Fertility; Fertilization in Vitro; Germ Cells; Male; Mice; Mice, Inbred ICR | 1993 |
Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Hot Temperature; Humans; Melanoma; Organoplatinum Compounds; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1993 |
A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Topics: Antineoplastic Agents; Carboplatin; Cells, Cultured; Cisplatin; DNA Damage; DNA Repair; Fanconi Anemia; Humans; Mutation; Xeroderma Pigmentosum | 1993 |
Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Teratocarcinoma; Testicular Neoplasms; Topoisomerase I Inhibitors; Transplantation, Heterologous; Vinblastine | 1997 |
The new anticancer drug [(2R)-aminomethylpyrrolidine](1, 1-cyclobutanedicarboxylato)platinum(II) and its toxic S enantiomer do interact differently with nucleic acids.
Topics: Antineoplastic Agents; Binding, Competitive; Carboplatin; Deoxyguanine Nucleotides; Deuterium Oxide; DNA; DNA Adducts; Guanosine Monophosphate; Kinetics; Models, Molecular; Nucleic Acid Conformation; Stereoisomerism; Temperature | 1999 |